Trajectories of kidney function in diabetes: a clinicopathological update

M Oshima, M Shimizu, M Yamanouchi… - Nature Reviews …, 2021 - nature.com
Diabetic nephropathy has been traditionally diagnosed based on persistently high
albuminuria and a subsequent decline in glomerular filtration rate (GFR), which is widely …

Risk prediction for early chronic kidney disease: results from an adult health examination program of 19,270 individuals

CC Shih, CJ Lu, GD Chen, CC Chang - International Journal of …, 2020 - mdpi.com
Developing effective risk prediction models is a cost-effective approach to predicting
complications of chronic kidney disease (CKD) and mortality rates; however, there is …

Sexually dimorphic response to tobacco in the development of chronic kidney disease: a systematic review

N Wu, R Chow, N Verhoeff, A Venkatraman, A Xiang… - BMC nephrology, 2024 - Springer
Introduction Chronic kidney disease (CKD) demonstrates a complex interaction with tobacco
exposure and sex differences, where females and males may experience varying risks and …

Novel plasma protein biomarkers from critically ill sepsis patients

LR Van Nynatten, M Slessarev, CM Martin… - Clinical Proteomics, 2022 - Springer
Background Despite the high morbidity and mortality associated with sepsis, the relationship
between the plasma proteome and clinical outcome is poorly understood. In this study, we …

Associations between sex and risk factors for predicting chronic kidney disease

HY Kao, CC Chang, CF Chang, YC Chen… - International journal of …, 2022 - mdpi.com
Gender is an important risk factor in predicting chronic kidney disease (CKD); however, it is
under-researched. The purpose of this study was to examine whether gender differences …

[HTML][HTML] Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice

VV Klimontov, AI Korbut, IS Taskaeva… - World Journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Modern guidelines recommend sodium-glucose cotransporter-2 (SGLT2)
inhibitors as the preferred antihyperglycemic agents for patients with type 2 diabetes and …

Multiplex bead array assay of a panel of circulating cytokines and growth factors in patients with albuminuric and non-albuminuric diabetic kidney disease

VV Klimontov, AI Korbut, NB Orlov, MV Dashkin… - Journal of Clinical …, 2020 - mdpi.com
A panel of cytokines and growth factors, mediating low-grade inflammation and fibrosis, was
assessed in patients with type 2 diabetes (T2D) and different patterns of chronic kidney …

Urinary markers of tubular injury and renal fibrosis in patients with type 2 diabetes and different phenotypes of chronic kidney disease

AI Korbut, VV Romanov, VV Klimontov - Life, 2023 - mdpi.com
This study assessed the urinary excretion of markers and mediators of tubular injury and
renal fibrosis in patients with type 2 diabetes (T2D) and non-albuminuric and albuminuric …

[HTML][HTML] Non-albuminuric diabetic kidney disease phenotype: beyond albuminuria

L D'Marco, X Guerra-Torres, I Viejo… - touchREVIEWS in …, 2022 - ncbi.nlm.nih.gov
Diabetic kidney disease (DKD) is the leading cause of chronic and end-stage kidney
disease worldwide. Its pathogenic mechanism is complex, and it can affect the entire …

Хроническая болезнь почек при сахарном диабете

ВВ Климонтов, АИ Корбут - 2020 - elibrary.ru
Пособие посвящено вопросам патогенеза, клиники, диагностики и лечения
хронической болезни почек при сахарном диабете. Представлена современная …